Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06600152 · ClinicalTrials.gov registry record · NA
Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients With Clean Surgical Wounds.
A NA study of Wound Heal, sponsored by Tempo Therapeutics.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 3
- Study locations
NCT06600152: Active NA study of Wound Heal, sponsored by Tempo Therapeutics.
NCT06600152 is a NA study of Wound Heal that is active but no longer recruiting, run by Tempo Therapeutics. The registered enrollment target is 40 participants, below the 118-participant average among 23 other Wound Heal trials with a reported enrollment target (66% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06600152, a NA study of Wound Heal, is active but no longer recruiting, sponsored by Tempo Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 3
- Study locations
Study Summary
A randomized, open-label, investigational safety evaluation of the Microporous Annealed Particle (MAP) Wound Matrix (TT101) device as a volumetric biomaterial scaffold applied to clean wounds after skin cancer surgery with Mohs micrographic surgery (MMS) compared to control.
Primary Outcome
Incidence of serious adverse device effects (SADE) (including delays in wound healing and surgical site infections) in subjects treated with MAP Wound Matrix, compared to the control group.
Conditions Studied
Interventions
- DEVICE MAP Wound Matrix
- DEVICE DuoDerm
Study Locations (3)
California
- Cal Coast Dermatology - Encino
Indiana
- Laser and Skin Surgery Center of Indiana - Indianapolis
Texas
- Studies in Dermatology - Cypress
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-08-26 |
| Est. Completion | 2026-08-30 |
| Phase | NA |
What the registry record for NCT06600152 still lists
NCT06600152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 118-participant average among 23 other Wound Heal trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Wound Heal appearing as the primary indexed condition, and to 2 interventions - of which MAP Wound Matrix is the first listed.
NCT06600152 reports a single indexed study location in California, Indiana, Texas.
Frequently Asked Questions
What is clinical trial NCT06600152 about?
NCT06600152 is a clinical study titled "Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients With Clean Surgical Wounds.". A randomized, open-label, investigational safety evaluation of the Microporous Annealed Particle (MAP) Wound Matrix (TT101) device as a volumetric biomaterial scaffold applied to clean wounds after skin cancer surgery with Mohs micrographic surgery (MMS) compared to control.
What is the current status of trial NCT06600152?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-08-26. Estimated completion is 2026-08-30.
What conditions does trial NCT06600152 study?
This clinical trial studies the following conditions: Wound Heal.
What interventions are being tested in trial NCT06600152?
The interventions under investigation include: MAP Wound Matrix (DEVICE), DuoDerm (DEVICE).
Who is sponsoring clinical trial NCT06600152?
This trial is sponsored by Tempo Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06600152 being conducted?
This trial has 3 study locations across California, Indiana, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Heal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06600152's enrollment target sits among peer trials
40 16th of 23 higher than 7 of 23 other Wound Heal trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound Heal trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Dermabrasion in Mohs: Split-Scar Trial
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
EDX110 Randomized Control Trial for Treatment of DFUs
RECRUITING · NA
-
Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds
RECRUITING · NA
-
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI